Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DeepX Diagnostics is an Australian health technology company focused on the early detection of skin cancer using artificial intelligence. The company was founded as a spin-out from the University of Queensland to commercialize advanced deep learning algorithms for dermatological imaging. Their primary product is an AI-driven diagnostic support tool that analyzes skin lesions to identify melanoma and other skin cancers with high precision. By integrating this technology into clinical workflows and mobile platforms, DeepX aims to increase the accessibility of skin screenings and improve patient outcomes through earlier intervention. The company's solutions are designed for use by both medical professionals and consumers to facilitate proactive skin health management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DeepX Diagnostics.